A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome
- PMID: 8237919
- DOI: 10.1001/archpedi.1993.02160350110017
A study of the physical, behavioral, and medical phenotype, including anthropometric measures, of females with fragile X syndrome
Abstract
The physical features of fragile X, including a long face, prominent ears, and hyperextensible joints, are present in affected males and females. Cytogenetically negative heterozygotes have been considered to be unaffected by the fragile X mental retardation-1 (FMR-1) gene. This study investigated the penetrance of the FMR-1 gene in cytogenetically negative but DNA-positive heterozygotes with a premutation (cytosine guanine guanine [CGG] amplification in the 50 to 200 repeat range), compared with carriers with a full mutation (> 200 CGG repeats) and control subjects. One hundred thirty-nine women with normal IQs between the ages of 18 and 45 years were studied. All underwent cytogenetic and DNA testing to determine their fragile X carrier status. A medical history-taking and a physical examination, including selected anthropometric measurements, were performed. Results indicate that the FMR-1 mutation mildly affects the physical phenotype of individuals even in the premutation state, although less dramatically than more affected heterozygotes. Carriers with a premutation differed significantly from control subjects in overall physical index score and in the anthropometric measure of ear prominence. These results suggest a phenotypic impact of the FMR-1 mutation even at the 50 to 200 CGG repeat length.
Similar articles
-
Direct DNA testing for fragile X syndrome.Am J Dis Child. 1993 Nov;147(11):1231-5. doi: 10.1001/archpedi.1993.02160350105016. Am J Dis Child. 1993. PMID: 7901988
-
Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.JAMA. 1994 Feb 16;271(7):507-14. JAMA. 1994. PMID: 8301764
-
Assessment of a clinical checklist in the diagnosis of fragile X syndrome in India.J Clin Neurosci. 2009 Oct;16(10):1305-10. doi: 10.1016/j.jocn.2008.12.018. Epub 2009 Jun 27. J Clin Neurosci. 2009. PMID: 19560928
-
Fragile X syndrome.Adv Pediatr. 1994;41:305-42. Adv Pediatr. 1994. PMID: 7992687 Review.
-
Molecular pathology of the fragile X syndrome.Arch Pathol Lab Med. 1993 Nov;117(11):1121-5. Arch Pathol Lab Med. 1993. PMID: 8239933 Review.
Cited by
-
Fragile X syndrome screening in Chinese children with unknown intellectual developmental disorder.BMC Pediatr. 2015 Jul 15;15:77. doi: 10.1186/s12887-015-0394-8. BMC Pediatr. 2015. PMID: 26174701 Free PMC article.
-
Quantitative comparison of FMR1 gene expression in normal and premutation alleles.Am J Hum Genet. 1995 Jan;56(1):106-13. Am J Hum Genet. 1995. PMID: 7825564 Free PMC article.
-
Fragile X syndrome. Molecular and clinical insights and treatment issues.West J Med. 1997 Feb;166(2):129-37. West J Med. 1997. PMID: 9109330 Free PMC article. Review.
-
Clinical and molecular implications of mosaicism in FMR1 full mutations.Front Genet. 2014 Sep 17;5:318. doi: 10.3389/fgene.2014.00318. eCollection 2014. Front Genet. 2014. PMID: 25278957 Free PMC article.
-
Fragile X-associated disorders: a clinical overview.J Neurol. 2012 Mar;259(3):401-13. doi: 10.1007/s00415-011-6161-3. Epub 2011 Jul 12. J Neurol. 2012. PMID: 21748281 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical